Datasets:
Tasks:
Token Classification
Modalities:
Text
Formats:
parquet
Sub-tasks:
named-entity-recognition
Size:
1K - 10K
License:
| license: mit | |
| task_categories: | |
| - token-classification | |
| task_ids: | |
| - named-entity-recognition | |
| dataset_info: | |
| features: | |
| - name: sentence | |
| dtype: string | |
| - name: entities | |
| list: | |
| - name: end | |
| dtype: int64 | |
| - name: label | |
| dtype: string | |
| - name: start | |
| dtype: int64 | |
| - name: text | |
| dtype: string | |
| - name: data_source | |
| dtype: string | |
| splits: | |
| - name: train | |
| num_bytes: 859293 | |
| num_examples: 3361 | |
| - name: validation | |
| num_bytes: 447206 | |
| num_examples: 1819 | |
| download_size: 564719 | |
| dataset_size: 1306499 | |
| configs: | |
| - config_name: default | |
| data_files: | |
| - split: train | |
| path: data/train-* | |
| - split: validation | |
| path: data/validation-* | |
| --- | |
| # Proposed Active Learning Data split | |
| ## Overview | |
| This dataset release represents a proposed and experimental data split designed specifically to support and validate planned active learning (AL) cycles for biomedical Named Entity Recognition (NER). | |
| The current version is not a final benchmark split. Instead, it serves as an initial, controlled setup for testing active learning strategies, model uncertainty sampling, | |
| and iterative annotation workflows prior to large-scale development. | |
| Both splits (train and validation) have been carefully curated to ensure coverage of all three target entity types: | |
| - **CellLine** | |
| - **CellType** | |
| - **Tissue** | |
| This balanced representation is critical for meaningful evaluation of active learning behavior across heterogeneous biomedical entities. | |
| ## Dataset Description | |
| Each of the split contain the following features: | |
| - sentence: list of sentences | |
| - entities: list of dict of entities found in sentences | |
| - data_source: the source of the article where the sentence orginates | |
| The dataset has been curated from three complementary biomedical domains, each contributing distinct entity distributions: | |
| 1. Single-Cell transciptomics: rich in CellTypes and Tissues | |
| 2. ChembL assay desriptions: rich in CellLines | |
| 3. Stem-Cell research: contains all 3 entities | |
| The stem cell–related articles were collected from the CellFinder data repository. | |
| The creation and annotation methodology of the original CellFinder dataset are described in the following reference: | |
| >Mariana Neves, Alexander Damaschun, Andreas Kurtz, Ulf Leser (2012) | |
| >Annotating and evaluating text for stem cell research. | |
| >In Proceedings Third Workshop on Building and Evaluation Resources for Biomedical Text Mining (BioTxtM 2012), | |
| >Language Resources and Evaluation (LREC) 2012. | |
| ## Article PMCIDs and source | |
| ### Train Set | |
| | PMCID | In-Split | Source | | |
| |-------|---------|--------| | |
| | PMC12435838 | train | Single-Cell | | |
| | PMC11578878 | train | Single-Cell | | |
| | PMC12396968 | train | Single-Cell | | |
| | PMC11116453 | train | Single-Cell | | |
| | PMC12408821 | train | Single-Cell | | |
| | PMC10968586 | train | CheMBL-V1 | | |
| | PMC10761218 | train | CheMBL-V1 | | |
| | PMC7642379 | train | CheMBL-V1 | | |
| | PMC10674574 | train | CheMBL-V1 | | |
| | PMC1315352 | train | CellFinder | | |
| | PMC2041973 | train | CellFinder | | |
| | PMC2238795 | train | CellFinder | | |
| ### Validation Set | |
| | PMCID | In-Split | Source | | |
| |-------|---------|--------| | |
| | PMC12256823 | val | Single-Cell | | |
| | PMC12116388 | val | Single-Cell | | |
| | PMC10287567 | val | Single-Cell | | |
| | PMC12133578 | val | Single-Cell | | |
| | PMC8658661 | val | CheMBL-V1 | | |
| | PMC11350568 | val | CheMBL-V1 | | |
| | PMC12072392 | val | CheMBL-V2/CeLLaTe-V2 | | |
| | PMC12115102 | val | CheMBL-V2/CeLLaTe-V2 | | |
| | PMC2063610 | val | CellFinder | | |
| | PMC1462997 | val | CellFinder | | |
| --- | |
| ## Intended Use | |
| ### Primary Use | |
| - Supervised NER training for biomedical NLP tasks | |
| ### Not Intended For | |
| - Clinical or patient-level decision making | |
| --- | |
| ## Notes and Limitations | |
| - This is an experimental split, subject to change. | |
| - Entity distributions may not reflect real-world prevalence. | |
| - Annotation density varies across domains by design | |